Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.
Spinifex Pharmaceuticals Appoints Dr. Declan Doogan as Non-Executive Chairman.
Latest News & Events
27TH MARCH 2013 Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of ... More
30TH JANUARY 2013 Pivotal EMA401 mechanism of action data has now been published in the European Journal of ... More
10TH DECEMBER 2012 Spinifex Initiates Phase 2 Proof-Of-Concept Clinical Trial in Chemotherapy Induced Neuropathy ... More